Webinar: Harnessing the Power of Bispecific Antibodies

This webinar at Creative Biolabs has invited experts from the University of Virginia and Institute for Research in Biomedicine to discuss how they expect and use bispecific antibodies in cancer therapies and virus neutralization.

Specifically, how:

1. Armed metabolism with bispecific antibodies enhances headless CAR T cells The design of the bispecific antibody is equipped with metabolically enhanced headless CAR T cells (hCART). The production of bispecific antibodies equips the metabolically enhanced hCART. Armed metabolism with bispecific antibodies enhances the efficacy of hCART in preclinical studies. 

2. Bispecific antibodies can protect mice from SARS-CoV-2 mutations and prevent the virus from escaping Development of bispecific IgG1-like molecules (CoV-X2). CoV-X2 neutralized wild-type SARS-CoV-2 and its variants in preclinical studies. CoV-X2 protects mice from infection and inhibits virus escape.